Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,063 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Co-expression of ERCC1 and Snail is a prognostic but not predictive factor of cisplatin-based neoadjuvant chemotherapy for bladder cancer.
Kawashima A, Takayama H, Kawamura N, Doi N, Sato M, Hatano K, Nagahara A, Uemura M, Nakai Y, Nishimura K, Miyoshi S, Kawano K, Nishimura K, Nonomura N, Tsujimura A. Kawashima A, et al. Among authors: miyoshi s. Oncol Lett. 2012 Jul;4(1):15-21. doi: 10.3892/ol.2012.689. Epub 2012 Apr 23. Oncol Lett. 2012. PMID: 22807952 Free PMC article.
[Plasmacytoid urothelial carcinoma of the bladder: a case report].
Kawashima A, Ujike T, Nin M, Nishimura K, Miyoshi S. Kawashima A, et al. Among authors: miyoshi s. Nihon Hinyokika Gakkai Zasshi. 2009 Jul;100(5):590-4. doi: 10.5980/jpnjurol.100.590. Nihon Hinyokika Gakkai Zasshi. 2009. PMID: 19663248 Free article. Review. Japanese.
Clinical outcome and prognostic factors of sorafenib in Japanese patients with advanced renal cell carcinoma in general clinical practice.
Tanigawa G, Kawashima A, Yamaguchi S, Nishimura K, Miyoshi S, Kajikawa J, Meguro N, Yosioka T, Oka T, Hara T, Takayama H, Nonomura N; Osaka Renal Cell Carcinoma Clinical Study Collaboration. Tanigawa G, et al. Among authors: miyoshi s. Jpn J Clin Oncol. 2011 Nov;41(11):1265-70. doi: 10.1093/jjco/hyr137. Epub 2011 Sep 29. Jpn J Clin Oncol. 2011. PMID: 21965163
Importance of continuing therapy and maintaining one-month relative dose intensity in sunitinib therapy for metastatic renal cell carcinoma.
Kawashima A, Tsujimura A, Takayama H, Arai Y, Nin M, Tanigawa G, Yasunaga Y, Mukai M, Uemura M, Nakai Y, Nishimura K, Nonomura N; Osaka Renal Cell Carcinoma Clinical Study Collaboration. Kawashima A, et al. Med Oncol. 2012 Dec;29(5):3298-305. doi: 10.1007/s12032-012-0236-6. Epub 2012 Apr 29. Med Oncol. 2012. PMID: 22544539
1,063 results